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“NON-CANONIC” ROLES OF PLATELETS: INFLAMMATION,
ANGIOGENESIS AND TISSUE REGENERATION
Platelets are small, oval, circulating, anucleate cells that upon endothelial damage form a
haemostatic plug and stop blood leakage. Circulating platelets derive from bone-marrow-resident
megakaryocytes that daily produce and release approximately 100 billions of new platelets into
the blood stream (Kaushansky, 2006; Semple et al., 2011). During haemostasis, tethering platelets
adhere to the vascular injury through the interaction between their glycoprotein (GP) Ib/V/IX
receptor complex and GPVI/GP Ia with the vonWillebrand factor (vWF) and collagen provided by
the lesioned environment, respectively. Adherent platelets aggregate and secrete platelet activation
mediators, such as Thromboxane A2 (TXA2) and adenosine diphosphate (ADP). After activation,
the platelets membrane surface becomes procoagulant enhancing the coagulation cascade ending
in the formation and stabilization of the haemostatic plug and arresting blood leakage.
Platelet function is not restricted to haemostasis, as platelets also have inflammatory, angiogenic,
and tissue repair properties (Nurden, 2011). Within their storage compartments (α-granules and
dense granules), platelets store a plethora of bioactive molecules that, under specific circumstances,
are secreted to the extracellular space targeting other cell types. Platelets-derived molecules include
proteins such as chemokines, cytokines, and growth factors, as well as RNAs and microparticles
(Brill et al., 2005; Chen et al., 2012; Lohmann et al., 2012; Schallmoser and Strunk, 2013;
Warnke et al., 2013). Platelets granules contain several pro-inflammatory and anti-inflammatory
molecules that contribute to immunity. In fact, platelets react against pathogens and regulate
immune cells function (reviewed in Semple et al., 2011). For example, during inflammation,
GPIbα, and P-selectin located at the surface of platelets interact with PSGL-1 and Mac-1 on
monocytes/macrophages inducing their recruitment and activation (reviwed in Gawaz et al., 2005).
Also, CD154 in activated platelets (Henn et al., 1998) binds to CD40 on endothelial cells (ECs)
inducing the expression of cell adhesion molecules (i.e., VCAM1, ICAM1) and the endothelial
release of CC-chemokine ligand 2 (CCL2) promoting the leukocyte recruitment to inflammatory
sites (Andre et al., 2002). Moreover, CD154 supports B cell differentiation (Elzey et al., 2003;
Von Hundelshausen and Weber, 2007) and platelet-secreted transforming growth factor beta
(TGF-β) controls Treg cell differentiation (Tran, 2012) indicating that the contribution of platelets
to immunity is not restricted to the innate system but also involves adaptive response.
Platelets apparently also shape angiogenesis, which is a complex process that consists in
the formation/sprouting of new capillaries from preexisting vessels. Platelets have a dual role.
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First, they stimulate ECs proliferation and can promote capillary
formation (Pipili-Synetos et al., 1998). Indeed, α-granules
contain several pro-angiogenic molecules that are secreted upon
the activation of platelets, such as vascular endothelial growth
factor (VEGF), platelet-derived growth factor (PDGF), TGF-
β, basic fibroblast growth factor (bFGF), epidermal growth
factor (EGF), sphingosine-1-phosphate (S1P), etc (Kaplan et al.,
1979; Heldin et al., 1981; Nakamura et al., 1985; Folkman and
Klagsbrun, 1987; Ben-Ezra et al., 1990; Mohle et al., 1997; English
et al., 2000; Jonnalagadda et al., 2014). Second, platelets are
required to avoid leakage from angiogenic vessels and their
absence inhibits the formation of new vessels in vivo (Kisucka
et al., 2006).
Haemostasis, inflammation and angiogenesis are essential
processes for tissue repair; thus, platelets are critically involved
in many mechanisms that operate along the healing process
(reviewed in Gurtner et al., 2008; Gawaz and Vogel, 2013).
Upon tissue damage provoked by trauma or local ischemia,
circulating platelets accumulate and become activated at
the lesion site releasing their bioactive molecules into the
damaged microenvironment and contributing to tissue
repair and regeneration. For instance, stromal cell-derived
factor-1 (SDF-1), hepatocyte growth factor (HGF), PDGF,
serotonin, ADP, and platelets-derived microparticles regulate
recruitment, proliferation, survival, and differentiation not only
of immune cells (neutrophils, monocytes) necessary for the
local inflammatory and the phagocytic responses, but also of
cells that directly repair the lesion such as fibroblast, smooth
muscle cells and tissue-specific progenitor cells (Nakamura et al.,
1986; Crowley et al., 1994; Stellos et al., 2008, 2010; Mazzucco
et al., 2010).
PLATELETS INFLUENCE CNS
INFLAMMATION: IMPACT ON REPAIR?
Regardless of its immune privileged condition and the presence
of the blood-brain-barrier (BBB), the CNS is not free from
the action of platelets, particularly, in response to injury. As
expected, after their adherence to endothelial cells, platelets
activate, and recruit leukocytes into the damaged CNS tissue
(Simon, 2012; Langer and Chavakis, 2013), thus, platelets
interact with different cells in the neurovascular niche including
neurons, glial cells, endothelial cells, pericytes, and other blood-
derived cells (Hayon et al., 2013; Sotnikov et al., 2013).
This particular feature confers platelets a substantial role in
CNS inflammation in different pathological scenarios. After
stroke, platelets adhere to the endothelium and get activated
provoking further thrombo-inflammatory events exaggerating
infarct development (Kleinschnitz et al., 2007; Nieswandt et al.,
2011). In Alzheimer’s disease (AD) the BBB is partially leaky and
vascular inflammation occurs (Sardi et al., 2011). Interestingly,
platelets might be contributing to the propagation of AD as
they carry amyloid precursor protein and the amyloid beta,
two peptides that are found around vessels in AD patients
that constitute one of the molecular mechanisms for AD
pathogenesis (Skovronsky et al., 2001; Catricala et al., 2012).
In multiple sclerosis (MS), an autoimmune CNS demyelinating
disease, platelets also seem to be involved to the pathology
since they have been found in human chronic active MS lesions
(Lock et al., 2002; Langer et al., 2012; Steinman, 2012). In an
animal model for MS, platelets promote leukocyte infiltration
as well as CNS inflammation (Lock et al., 2002; Langer et al.,
2012). Therefore, platelets contribute to neuroinflammation
and an altered platelet functions may lead to pathological
conditions.
Besides their role in pathogenesis, platelets might also be
involved in the regulation of regenerative processes by interacting
with CNS stem/progenitor cells. Adult neural stem cells (NSCs)
are undifferentiated self-renewing multipotent cells that reside
in the subgranular zone (SGZ) in the dentate gyrus of the
hippocampus and in the subventricular zone (SVZ) of the wall
of the lateral ventricles (Altman, 1965; Gage, 2000; Alvarez-
Buylla and Garcia-Verdugo, 2002). Oligodendrocyte progenitor
cells (OPCs) represent themajor cellular source for remyelinating
oligodendrocytes and are widely spread throughout the CNS
(Ffrench-Constant and Raff, 1986; Woodruff and Franklin,
1999; Franklin and Ffrench-Constant, 2008). Interestingly,
NSCs and OPCs drive CNS repair in response to stroke
or to MS-associated demyelination (Arvidsson et al., 2002;
Franklin, 2002; Kokaia and Lindvall, 2003; Gonzalez-Perez et al.,
2009). While neuroinflammation was mainly considered to
be an aggravating factor, several recent studies have revealed
a supportive role in CNS repair (Patel et al., 2010; Jaerve
and Muller, 2012; Miron and Franklin, 2014). For example,
the very complex process of remyelination (Franklin and
Ffrench-Constant, 2008; Rivera et al., 2010) involves a crucial
inflammatory stage that precedes regeneration and occurs acutely
after myelin damage. This innate immune response is, at
least partially, mediated by blood-recruited macrophages and
CNS-resident microglial cells. During remyelination, circulating
monocytes/macrophages are recruited by chemotaxis (Charo
and Ransohoff, 2006; Ruckh et al., 2012) and, depending on
their inflammatory state, exert the following functional roles:
(i) they are responsible for the removal (clearance) of myelin
debris [which is a potent inhibitor of OPC differentiation (Kotter
et al., 2006; Baer et al., 2009)] through phagocytosis, and
(ii) they secrete cytokines, growth- and neurotrophic factors
that stimulate OPC responses to demyelination (Setzu et al.,
2006; Zhao et al., 2006; Ruckh et al., 2012; Miron et al.,
2013). A regulation of macrophage recruitment and activity
is essential to couple inflammation and regeneration during
CNS myelin repair (Miron and Franklin, 2014). However,
the cellular and molecular cues that regulate these events
are still unknown. As previously mentioned, platelets promote
the endothelial secretion of chemokines known to recruit
circulating monocytes/macrophages (Gawaz et al., 1998, 2000).
Furthermore, through the secretion of PDGF and platelet factor
4 (PF-4), activated platelets directly promote the recruitment of
monocytes and modulate their activity (Deuel et al., 1982; Brandt
et al., 2000; Fricke et al., 2004). Thus, it can be hypothesized
that circulating platelets might influence macrophage/microglia
recruitment and activity thereby linking neuroinflammation to
CNS repair.
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PLATELETS MODULATE CNS-RESIDENT
STEM/PROGENITOR CELL FUNCTION:
IMPACT ON REPAIR?
Supporting the previous hypothesis, a series of findings suggest
that platelets directly exert CNS-regenerative activities and
might contribute to neuroregeneration (see Table 1). Recently
we reported that upon demyelination in the corpus callosum
(CC), platelets specifically accumulate within the ipsilateral SVZ
vasculature, a process associated with an enhanced survival
of SVZ-resident NSCs (Kazanis et al., 2015). Importantly, we
found that a mechanical non-demyelinating lesion within the
CC is not enough to induce such accumulation of platelets
in the SVZ vasculature, indicating that cellular degeneration is
required for such an effect. Considering that SVZ-derived NSCs
contribute to remyelination in the CC (Jablonska et al., 2010;
Xing et al., 2014), these findings suggest that platelets might play
a role in controlling the NSCs pool available for CNS repair.
The mechanisms that mediate the very specific accumulation
of platelets in the SVZ vasculature far from the lesion site,
and that promote NSCs survival are not known. However,
platelets derived molecules might be involved as in the same
study we found that platelet lysate (PL) protects proliferating
NSCs from apoptosis (Kazanis et al., 2015). Furthermore, it
has been previously suggested that activated platelets contribute
to recovery after brain injury (Hayon et al., 2012c). For
example, it has been shown in an animal model for stroke
that infused platelets derived microparticles (PMP) increased
cell proliferation, neurogenesis and angiogenesis at the infarct
boundary zone leading to improvements in behavioral outcomes
(Hayon et al., 2012a). In addition to this, a different study
showed that PMP promotes NSCs survival and increased their
differentiation potential to glia and neurons (Hayon et al.,
2012b). Also, upon intracerebroventricular administration of PL
into an experimental model of stroke resulted in a significant
increase in angiogenesis and in the number of proliferating
SVZ-resident NSCs (Hayon et al., 2013). Besides these findings,
several platelets derived molecules influence CNS progenitor
function (see Table 1). For instance, the dense granules of
platelets contain serotonin (White, 1968), which is known to
control NSCs activity and adult neurogenesis (Brezun and
Daszuta, 1999; Banasr et al., 2004; Goto et al., 2016). The
effect of platelets derived molecules might not only target NSCs
but also OPCs during remyelination. For instance, platelets’ α-
granules contain large quantities of PDGF and bFGF (Lohmann
et al., 2012; Schallmoser and Strunk, 2013), factors that are
known to promote OPCs survival, proliferation, and recruitment
(Woodruff et al., 2004; Murtie et al., 2005; Zhou et al., 2006).
Moreover, upon activation, platelets’ α-granules secrete S1P
(English et al., 2000; Jonnalagadda et al., 2014), a molecule,
that is known to modulate OPCs survival, proliferation, and
differentiation (Jung et al., 2007). In summary, platelets react
to injury and secrete a plethora of bioactive molecules that
might directly influence NSCs and OPCs function, probably,
modulating CNS repair. This hypothesis could be evaluated
by studying neuroregeneration in animal models that display
platelet deficiencies (number and/or function). Also, by exploring
gene expression databases complemented with proteomics data,
further studies could identify molecules contained in platelets
that may influence CNS repair.
FINAL REMARKS
There is accumulating evidence that the role of platelets is not
restricted to haemostasis, but it also involves the regulation of
inflammation, angiogenesis and tissue repair. The CNS contains
NSCs and OPCs that contribute to cellular turnover and CNS
repair. In light of the accumulating evidence that associates
TABLE 1 | Evidences suggesting possible direct contribution of platelets in CNS repair.
Platelets derived
activity or factor
Experimental Model Findings References
Circulating Platelets Lysolecithin-induced demyelination in the CC Platelets aggregation in the SVZ vasculature associated to
NSCs survival
Kazanis et al., 2015
Platelet lysate (PL) In vitro proliferating NSCs PL promotes NSCs survival and protects from apoptosis Kazanis et al., 2015
Platelets-derived
microparticles (PMP)
Permanent middle cerebral artery occlusion
(PMCAO). PMP administrated to the brain
surface
PMP increases cell proliferation, neurogenesis, and
angiogenesis
Hayon et al., 2012a
PMP In vitro NSCs PMP promotes survival and increases the differentiation
potential of NSCs
Hayon et al., 2012b
PL PMCAO. PL administrated into the lateral
ventricles
PL increases the number of NSC and angiogenesis in the
subventricular zone (SVZ) as well as in the peri-lesion cortex
Hayon et al., 2013
Serotonin (contained in
dense granules)
In vivo normal wild type rats. Systemic
administration of serotonin
Serotonin regulate NSCs proliferation in the SVZ and
hippocampus and modulate adult neurogenesis
Banasr et al., 2004
PDGF and bFGF
(contained in α-granules)
Cuprizone-induced demyelination in
PDGFαR+/− mice, FGF2 knockout (−/−)
mice, and PDGFαR+/− FGF2−/− mice
PDGF and bFGF regulate OPCs proliferation and
differentiation during CNS remyelination
Murtie et al., 2005
S1P (contained in
α-granules)
In vitro OPCs. Use of S1P analogs: FTY720
and FTY720P, both modulators of S1P
receptors
By different mechanisms S1P and its receptors regulate
OPCs proliferation, survival, and differentiation
Jung et al., 2007
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platelets to neuroinflammation, especially under pathological
conditions, their potential role in CNS repair has to be further
investigated. Recent findings indicate that neuroinflammation is
also relevant for CNS repair as it contributes to debris clearance
and controls CNS-resident stem/progenitor cells function,
suggesting a potential role for platelets by linking inflammation
to regeneration. This hypothesis is supported by the facts that
circulating platelets react to CNS injury and accumulate within
the adult stem cell niche and that activated platelets release a
plethora of bioactive molecules that not only regulate immune
cells activity but also directly modulates NSC and OPC respond
to injury. It is, therefore, likely that platelets might modulate CNS
repair. Prospectively, this specific lesion-induced accumulation
of circulating platelets at sites of tissue damage, inflammation,
and even stem/progenitor cell activity (as in Kazanis et al., 2015)
opens the possibility to use genetically manipulated platelets or
manufactured platelet-like particles (Risitano et al., 2012; Brown
et al., 2014) when aiming for the delivery of specific molecules
directly to targeted areas.
AUTHOR CONTRIBUTIONS
FR wrote the manuscript. IK, CG, and LA critically reviewed the
manuscript. All authors read and approved the final version of
the manuscript.
ACKNOWLEDGMENTS
This work was supported by the State Government of Salzburg,
Austria, (Stifungsprofessur, and 20204-WISS/80/199-2014),
through funding from the European Union’s Seventh Framework
Program (FP7/2007–2013) under grant agreements n◦ HEALTH-
F2-2011-278850 (INMiND), n◦ HEALTH-F2-2011-279288
(IDEA), n◦ FP7-REGPOT-316120 (GlowBrain), the Austrian
Science Fund FWF Special Research Program (SFB) F44 (F4413-
B23) “Cell Signaling in Chronic CNS Disorders,” by the research
funds from the Paracelsus Medical University PMU-FFF (Long-
Term Fellowship L-12/01/001-RIV to FR and Stand Alone
grant 2058).
REFERENCES
Altman, J. (1965). Autoradiographic and Histological Evidence of Postnatal
Hippocampal Neurogenesis in Rats. J. Comp. Neurol. 124, 17. doi:
10.1002/cne.901240303
Alvarez-Buylla, A., and Garcia-Verdugo, J. M. (2002). Neurogenesis in
adult subventricular zone. J. Neurosci. 22, 629–634. Available online
at: http://www.jneurosci.org/content/22/3/629.short?sid=fbdb27ec-6535-
4f73-bb06-d948ca23c506
Andre, P., Nannizzi-Alaimo, L., Prasad, S. K., and Phillips, D. R. (2002). Platelet-
derived CD40L: the switch-hitting player of cardiovascular disease. Circulation
106, 896–899. doi: 10.1161/01.CIR.0000028962.04520.01
Arvidsson, A., Collin, T., Kirik, D., Kokaia, Z., and Lindvall, O. (2002). Neuronal
replacement from endogenous precursors in the adult brain after stroke. Nat.
Med. 8, 963–970. doi: 10.1038/nm747
Baer, A. S., Syed, Y. A., Kang, S. U., Mitteregger, D., Vig, R., Ffrench-Constant,
C., et al. (2009). Myelin-mediated inhibition of oligodendrocyte precursor
differentiation can be overcome by pharmacological modulation of Fyn-RhoA
and protein kinase C signalling. Brain 132, 465–481. doi: 10.1093/brain/
awn334
Banasr, M., Hery, M., Printemps, R., and Daszuta, A. (2004). Serotonin-
induced increases in adult cell proliferation and neurogenesis are mediated
through different and common 5-HT receptor subtypes in the dentate gyrus
and the subventricular zone. Neuropsychopharmacology 29, 450–460. doi:
10.1038/sj.npp.1300320
Ben-Ezra, J., Sheibani, K., Hwang, D. L., and Lev-Ran, A. (1990). Megakaryocyte
synthesis is the source of epidermal growth factor in human platelets. Am. J.
Pathol. 137, 755–759.
Brandt, E., Ludwig, A., Petersen, F., and Flad, H. D. (2000). Platelet-derived CXC
chemokines: old players in new games. Immunol. Rev. 177, 204–216. doi:
10.1034/j.1600-065X.2000.17705.x
Brezun, J. M., and Daszuta, A. (1999). Depletion in serotonin decreases
neurogenesis in the dentate gyrus and the subventricular zone of adult rats.
Neuroscience 89, 999–1002. doi: 10.1016/S0306-4522(98)00693-9
Brill, A., Dashevsky, O., Rivo, J., Gozal, Y., and Varon, D. (2005). Platelet-
derived microparticles induce angiogenesis and stimulate post-ischemic
revascularization. Cardiovasc. Res. 67, 30–38. doi: 10.1016/j.cardiores.2005.
04.007
Brown, A. C., Stabenfeldt, S. E., Ahn, B., Hannan, R. T., Dhada, K. S., Herman, E. S.,
et al. (2014). Ultrasoft microgels displaying emergent platelet-like behaviours.
Nat. Mater. 13, 1108–1114. doi: 10.1038/nmat4066
Catricala, S., Torti, M., and Ricevuti, G. (2012). Alzheimer disease and platelets:
how’s that relevant. Immun. Ageing 9:20. doi: 10.1186/1742-4933-9-20
Charo, I. F., and Ransohoff, R. M. (2006). The many roles of chemokines and
chemokine receptors in inflammation. N. Engl. J. Med. 354, 610–621. doi:
10.1056/NEJMra052723
Chen, B., Sun, H. H., Wang, H. G., Kong, H., Chen, F. M., and Yu, Q.
(2012). The effects of human platelet lysate on dental pulp stem cells
derived from impacted human third molars. Biomaterials 33, 5023–5035. doi:
10.1016/j.biomaterials.2012.03.057
Crowley, S. T., Dempsey, E. C., Horwitz, K. B., and Horwitz, L. D. (1994). Platelet-
induced vascular smooth muscle cell proliferation is modulated by the growth
amplification factors serotonin and adenosine diphosphate. Circulation 90,
1908–1918. doi: 10.1161/01.CIR.90.4.1908
Deuel, T. F., Senior, R. M., Huang, J. S., and Griffin, G. L. (1982). Chemotaxis of
monocytes and neutrophils to platelet-derived growth factor. J. Clin. Invest. 69,
1046–1049. doi: 10.1172/JCI110509
Elzey, B. D., Tian, J., Jensen, R. J., Swanson, A. K., Lees, J. R., Lentz, S. R., et al.
(2003). Platelet-mediated modulation of adaptive immunity. A communication
link between innate and adaptive immune compartments. Immunity 19, 9–19.
doi: 10.1016/S1074-7613(03)00177-8
English, D., Welch, Z., Kovala, A. T., Harvey, K., Volpert, O. V., Brindley, D. N.,
et al. (2000). Sphingosine 1-phosphate released from platelets during clotting
accounts for the potent endothelial cell chemotactic activity of blood serum
and provides a novel link between hemostasis and angiogenesis. FASEB J. 14,
2255–2265. doi: 10.1096/fj.00-0134com
Ffrench-Constant, C., and Raff, M. C. (1986). The oligodendrocyte-type-2
astrocyte cell lineage is specialized for myelination. Nature 323, 335–338. doi:
10.1038/323335a0
Folkman, J., and Klagsbrun, M. (1987). Angiogenic factors. Science 235, 442–447.
doi: 10.1126/science.2432664
Franklin, R. J. (2002). Why does remyelination fail in multiple sclerosis? Nat. Rev.
Neurosci. 3, 705–714. doi: 10.1038/nrn917
Franklin, R. J., and Ffrench-Constant, C. (2008). Remyelination in the CNS:
from biology to therapy. Nat. Rev. Neurosci. 9, 839–855. doi: 10.1038/
nrn2480
Fricke, I., Mitchell, D., Petersen, F., Bohle, A., Bulfone-Paus, S., and Brandau,
S. (2004). Platelet factor 4 in conjunction with IL-4 directs differentiation
of human monocytes into specialized antigen-presenting cells. FASEB J. 18,
1588–1590. doi: 10.1096/fj.03-1435fje
Gage, F. H. (2000). Mammalian neural stem cells. Science 287, 1433–1438. doi:
10.1126/science.287.5457.1433
Frontiers in Cellular Neuroscience | www.frontiersin.org 4 January 2016 | Volume 9 | Article 511
Rivera et al. Platelets in Neuroregeneration
Gawaz, M., Brand, K., Dickfeld, T., Pogatsa-Murray, G., Page, S., Bogner, C., et al.
(2000). Platelets induce alterations of chemotactic and adhesive properties of
endothelial cells mediated through an interleukin-1-dependent mechanism.
Implications for atherogenesis. Atherosclerosis 148, 75–85. doi: 10.1016/S0021-
9150(99)00241-5
Gawaz, M., Langer, H., and May, A. E. (2005). Platelets in inflammation and
atherogenesis. J. Clin. Invest. 115, 3378–3384. doi: 10.1172/JCI27196
Gawaz, M., Neumann, F. J., Dickfeld, T., Koch, W., Laugwitz, K. L., Adelsberger,
H., et al. (1998). Activated platelets induce monocyte chemotactic protein-
1 secretion and surface expression of intercellular adhesion molecule-1 on
endothelial cells. Circulation 98, 1164–1171. doi: 10.1161/01.CIR.98.12.1164
Gawaz, M., and Vogel, S. (2013). Platelets in tissue repair: control of apoptosis and
interactions with regenerative cells. Blood 122, 2550–2554. doi: 10.1182/blood-
2013-05-468694
Gonzalez-Perez, O., Romero-Rodriguez, R., Soriano-Navarro, M., Garcia-
Verdugo, J. M., and Alvarez-Buylla, A. (2009). Epidermal growth factor
induces the progeny of subventricular zone type B cells to migrate and
differentiate into oligodendrocytes. Stem Cells 27, 2032–2043. doi: 10.1002/
stem.119
Goto, K., Kawahara, I., Inada, H., Misawa, H., Kuniyasu, H., Nabekura, J.,
et al. (2016). Activation of 5-HT4 receptors facilitates neurogenesis from
transplanted neural stem cells in the anastomotic ileum. J. Physiol. Sci. 66,
67–76. doi: 10.1007/s12576-015-0396-1
Gurtner, G. C., Werner, S., Barrandon, Y., and Longaker, M. T. (2008). Wound
repair and regeneration. Nature 453, 314–321. doi: 10.1038/nature07039
Hayon, Y., Dashevsky, O., Shai, E., Brill, A., Varon, D., and Leker, R. R. (2012a).
Platelet microparticles induce angiogenesis and neurogenesis after cerebral
ischemia. Curr. Neurovasc. Res. 9, 185–192. doi: 10.2174/156720212801619018
Hayon, Y., Dashevsky, O., Shai, E., Varon, D., and Leker, R. R. (2012b).
Platelet microparticles promote neural stem cell proliferation, survival and
differentiation. J. Mol. Neurosci. 47, 659–665. doi: 10.1007/s12031-012-9711-y
Hayon, Y., Dashevsky, O., Shai, E., Varon, D., and Leker, R. R. (2013). Platelet
lysates stimulate angiogenesis, neurogenesis and neuroprotection after stroke.
Thromb. Haemost. 110, 323–330. doi: 10.1160/TH12-11-0875
Hayon, Y., Shai, E., Varon, D., and Leker, R. R. (2012c). The role of platelets
and their microparticles in rehabilitation of ischemic brain tissue. CNS Neurol.
Disord. Drug Targets 11, 921–925. doi: 10.2174/1871527311201070921
Heldin, C. H., Westermark, B., and Wasteson, A. (1981). Platelet-derived growth
factor. Isolation by a large-scale procedure and analysis of subunit composition.
Biochem. J. 193, 907–913. doi: 10.1042/bj1930907
Henn, V., Slupsky, J. R., Grafe, M., Anagnostopoulos, I., Forster, R., Muller-
Berghaus, G., et al. (1998). CD40 ligand on activated platelets triggers
an inflammatory reaction of endothelial cells. Nature 391, 591–594. doi:
10.1038/35393
Jablonska, B., Aguirre, A., Raymond, M., Szabo, G., Kitabatake, Y., Sailor, K. A.,
et al. (2010). Chordin-induced lineage plasticity of adult SVZ neuroblasts after
demyelination. Nat. Neurosci. 13, 541–550. doi: 10.1038/nn.2536
Jaerve, A., and Muller, H. W. (2012). Chemokines in CNS injury and repair. Cell
Tissue Res. 349, 229–248. doi: 10.1007/s00441-012-1427-3
Jonnalagadda, D., Sunkara, M., Morris, A. J., and Whiteheart, S. W. (2014).
Granule-mediated release of sphingosine-1-phosphate by activated platelets.
Biochim. Biophys. Acta 1841, 1581–1589. doi: 10.1016/j.bbalip.2014.08.013
Jung, C. G., Kim, H. J., Miron, V. E., Cook, S., Kennedy, T. E., Foster, C. A.,
et al. (2007). Functional consequences of S1P receptor modulation in rat
oligodendroglial lineage cells. Glia 55, 1656–1667. doi: 10.1002/glia.20576
Kaplan, D. R., Chao, F. C., Stiles, C. D., Antoniades, H. N., and Scher, C. D.
(1979). Platelet alpha granules contain a growth factor for fibroblasts. Blood
53, 1043–1052.
Kaushansky, K. (2006). Lineage-specific hematopoietic growth factors. N. Engl. J.
Med. 354, 2034–2045. doi: 10.1056/NEJMra052706
Kazanis, I., Feichtner, M., Lange, S., Rotheneichner, P., Hainzl, S., Oller, M.,
et al. (2015). Lesion-induced accumulation of platelets promotes survival
of adult neural stem / progenitor cells. Exp. Neurol. 269, 75–89. doi:
10.1016/j.expneurol.2015.03.018
Kisucka, J., Butterfield, C. E., Duda, D. G., Eichenberger, S. C., Saffaripour, S.,
Ware, J., et al. (2006). Platelets and platelet adhesion support angiogenesis while
preventing excessive hemorrhage. Proc. Natl. Acad. Sci. U.S.A. 103, 855–860.
doi: 10.1073/pnas.0510412103
Kleinschnitz, C., Pozgajova, M., Pham, M., Bendszus, M., Nieswandt, B.,
and Stoll, G. (2007). Targeting platelets in acute experimental stroke:
impact of glycoprotein Ib, VI, and IIb/IIIa blockade on infarct size,
functional outcome, and intracranial bleeding. Circulation 115, 2323–2330. doi:
10.1161/CIRCULATIONAHA.107.691279
Kokaia, Z., and Lindvall, O. (2003). Neurogenesis after ischaemic brain insults.
Curr. Opin. Neurobiol. 13, 127–132. doi: 10.1016/S0959-4388(03)00017-5
Kotter, M. R., Li, W. W., Zhao, C., and Franklin, R. J. (2006). Myelin impairs
CNS remyelination by inhibiting oligodendrocyte precursor cell differentiation.
J. Neurosci. 26, 328–332. doi: 10.1523/JNEUROSCI.2615-05.2006
Langer, H. F., and Chavakis, T. (2013). Platelets and neurovascular inflammation.
Thromb. Haemost. 110, 888–893. doi: 10.1160/TH13-02-0096
Langer, H. F., Choi, E. Y., Zhou, H., Schleicher, R., Chung, K. J., Tang, Z.,
et al. (2012). Platelets contribute to the pathogenesis of experimental
autoimmune encephalomyelitis. Circ. Res. 110, 1202–1210. doi:
10.1161/CIRCRESAHA.111.256370
Lock, C., Hermans, G., Pedotti, R., Brendolan, A., Schadt, E., Garren, H., et al.
(2002). Gene-microarray analysis of multiple sclerosis lesions yields new
targets validated in autoimmune encephalomyelitis. Nat. Med. 8, 500–508. doi:
10.1038/nm0502-500
Lohmann, M., Walenda, G., Hemeda, H., Joussen, S., Drescher, W., Jockenhoevel,
S., et al. (2012). Donor age of human platelet lysate affects proliferation
and differentiation of mesenchymal stem cells. PLoS ONE 7:e37839. doi:
10.1371/journal.pone.0037839
Mazzucco, L., Borzini, P., and Gope, R. (2010). Platelet-derived factors involved
in tissue repair-from signal to function. Transfus. Med. Rev. 24, 218–234. doi:
10.1016/j.tmrv.2010.03.004
Miron, V. E., Boyd, A., Zhao, J. W., Yuen, T. J., Ruckh, J. M., Shadrach, J. L., et al.
(2013). M2 microglia and macrophages drive oligodendrocyte differentiation
during CNS remyelination.Nat. Neurosci. 16, 1211–1218. doi: 10.1038/nn.3469
Miron, V. E., and Franklin, R. J. (2014). Macrophages and CNS remyelination.
J. Neurochem. 130, 165–171. doi: 10.1111/jnc.12705
Mohle, R., Green, D., Moore, M. A., Nachman, R. L., and Rafii, S. (1997).
Constitutive production and thrombin-induced release of vascular endothelial
growth factor by human megakaryocytes and platelets. Proc. Natl. Acad. Sci.
U.S.A. 94, 663–668. doi: 10.1073/pnas.94.2.663
Murtie, J. C., Zhou, Y. X., Le, T. Q., Vana, A. C., and Armstrong, R. C. (2005).
PDGF and FGF2 pathways regulate distinct oligodendrocyte lineage responses
in experimental demyelination with spontaneous remyelination. Neurobiol.
Dis. 19, 171–182. doi: 10.1016/j.nbd.2004.12.006
Nakamura, T., Teramoto, H., and Ichihara, A. (1986). Purification and
characterization of a growth factor from rat platelets for mature parenchymal
hepatocytes in primary cultures. Proc. Natl. Acad. Sci. U.S.A. 83, 6489–6493.
doi: 10.1073/pnas.83.17.6489
Nakamura, T., Tomita, Y., Hirai, R., Yamaoka, K., Kaji, K., and Ichihara, A.
(1985). Inhibitory effect of transforming growth factor-beta on DNA synthesis
of adult rat hepatocytes in primary culture. Biochem. Biophys. Res. Commun.
133, 1042–1050. doi: 10.1016/0006-291X(85)91241-0
Nieswandt, B., Kleinschnitz, C., and Stoll, G. (2011). Ischaemic stroke: a
thrombo-inflammatory disease? J. Physiol. (Lond). 589, 4115–4123. doi:
10.1113/jphysiol.2011.212886
Nurden, A. T. (2011). Platelets, inflammation and tissue regeneration. Thromb.
Haemost. 105(Suppl. 1), S13–S33. doi: 10.1160/THS10-11-0720
Patel, J. R., Mccandless, E. E., Dorsey, D., and Klein, R. S. (2010). CXCR4 promotes
differentiation of oligodendrocyte progenitors and remyelination. Proc. Natl.
Acad. Sci. U.S.A. 107, 11062–11067. doi: 10.1073/pnas.1006301107
Pipili-Synetos, E., Papadimitriou, E., and Maragoudakis, M. E. (1998). Evidence
that platelets promote tube formation by endothelial cells on matrigel. Br. J.
Pharmacol. 125, 1252–1257. doi: 10.1038/sj.bjp.0702191
Risitano, A., Beaulieu, L. M., Vitseva, O., and Freedman, J. E. (2012). Platelets and
platelet-like particles mediate intercellular RNA transfer. Blood 119, 6288–6295.
doi: 10.1182/blood-2011-12-396440
Rivera, F. J., Steffenhagen, C., Kremer, D., Kandasamy, M., Sandner, B., Couillard-
Despres, S., et al. (2010). Deciphering the oligodendrogenic program of neural
progenitors: cell intrinsic and extrinsic regulators. Stem Cells Dev. 19, 595–606.
doi: 10.1089/scd.2009.0293
Ruckh, J. M., Zhao, J.-W., Shadrach, J. L., Van wijngaarden, P., Rao, T. N.,
Wagers, A. J., et al. (2012). Rejuvenation of regeneration in the aging
Frontiers in Cellular Neuroscience | www.frontiersin.org 5 January 2016 | Volume 9 | Article 511
Rivera et al. Platelets in Neuroregeneration
central nervous system. Cell Stem Cell 10, 96–103. doi: 10.1016/j.stem.2011.
11.019
Sardi, F., Fassina, L., Venturini, L., Inguscio, M., Guerriero, F., Rolfo,
E., et al. (2011). Alzheimer’s disease, autoimmunity and inflammation.
The good, the bad and the ugly. Autoimmun. Rev. 11, 149–153. doi:
10.1016/j.autrev.2011.09.005
Schallmoser, K., and Strunk, D. (2013). Generation of a pool of human platelet
lysate and efficient use in cell culture. Methods Mol. Biol. 946, 349–362. doi:
10.1007/978-1-62703-128-8_22
Semple, J. W., Italiano, J. E. Jr., and Freedman, J. (2011). Platelets and the immune
continuum. Nat. Rev. Immunol. 11, 264–274. doi: 10.1038/nri2956
Setzu, A., Lathia, J. D., Zhao, C., Wells, K., Rao, M. S., Ffrench-Constant, C., et al.
(2006). Inflammation stimulates myelination by transplanted oligodendrocyte
precursor cells. Glia 54, 297–303. doi: 10.1002/glia.20371
Simon, D. I. (2012). Inflammation and vascular injury: basic discovery to drug
development. Circ. J. 76, 1811–1818. doi: 10.1253/circj.CJ-12-0801
Skovronsky, D. M., Lee, V. M., and Pratico, D. (2001). Amyloid precursor
protein and amyloid beta peptide in human platelets. Role of
cyclooxygenase and protein kinase C. J. Biol. Chem. 276, 17036–17043.
doi: 10.1074/jbc.M006285200
Sotnikov, I., Veremeyko, T., Starossom, S. C., Barteneva, N., Weiner, H. L.,
and Ponomarev, E. D. (2013). Platelets recognize brain-specific glycolipid
structures, respond to neurovascular damage and promote neuroinflammation.
PLoS ONE 8:e58979. doi: 10.1371/journal.pone.0058979
Steinman, L. (2012). The discovery of natalizumab, a potent therapeutic for
multiple sclerosis. J. Cell Biol. 199, 413–416. doi: 10.1083/jcb.201207175
Stellos, K., Kopf, S., Paul, A., Marquardt, J. U., Gawaz, M., Huard, J., et al.
(2010). Platelets in regeneration. Semin. Thromb. Hemost. 36, 175–184. doi:
10.1055/s-0030-1251502
Stellos, K., Langer, H., Daub, K., Schoenberger, T., Gauss, A., Geisler, T., et al.
(2008). Platelet-derived stromal cell-derived factor-1 regulates adhesion and
promotes differentiation of human CD34+ cells to endothelial progenitor cells.
Circulation 117, 206–215. doi: 10.1161/CIRCULATIONAHA.107.714691
Tran, D. Q. (2012). TGF-beta: the sword, the wand, and the shield of FOXP3(+)
regulatory T cells. J. Mol. Cell Biol. 4, 29–37. doi: 10.1093/jmcb/mjr033
Von Hundelshausen, P., and Weber, C. (2007). Platelets as immune cells:
bridging inflammation and cardiovascular disease. Circ. Res. 100, 27–40. doi:
10.1161/01.RES.0000252802.25497.b7
Warnke, P. H., Humpe, A., Strunk, D., Stephens, S., Warnke, F., Wiltfang, J.,
et al. (2013). A clinically-feasible protocol for using human platelet lysate and
mesenchymal stem cells in regenerative therapies. J. Craniomaxillofac. Surg. 41,
153–161. doi: 10.1016/j.jcms.2012.07.003
White, J. G. (1968). The dense bodies of human platelets. Origin of serotonin
storage particles from platelet granules. Am. J. Pathol. 53, 791–808.
Woodruff, R. H., and Franklin, R. J. (1999). Demyelination and remyelination
of the caudal cerebellar peduncle of adult rats following stereotaxic injections
of lysolecithin, ethidium bromide, and complement/anti-galactocerebroside: a
comparative study. Glia 25, 216–228.
Woodruff, R. H., Fruttiger, M., Richardson, W. D., and Franklin, R. J.
M. (2004). Platelet-derived growth factor regulates oligodendrocyte
progenitor numbers in adult CNS and their response following CNS
demyelination. Mol. Cell. Neurosci. 25, 252–262. doi: 10.1016/j.mcn.2003.
10.014
Xing, Y. L., Roth, P. T., Stratton, J. A., Chuang, B. H., Danne, J., Ellis, S. L., et al.
(2014). Adult neural precursor cells from the subventricular zone contribute
significantly to oligodendrocyte regeneration and remyelination. J. Neurosci.
34, 14128–14146. doi: 10.1523/JNEUROSCI.3491-13.2014
Zhao, C., Li, W. W., and Franklin, R. J. (2006). Differences in the early
inflammatory responses to toxin-induced demyelination are associated with the
age-related decline in CNS remyelination.Neurobiol. Aging 27, 1298–1307. doi:
10.1016/j.neurobiolaging.2005.06.008
Zhou, Y. X., Flint, N. C., Murtie, J. C., Le, T. Q., and Armstrong, R. C.
(2006). Retroviral lineage analysis of fibroblast growth factor receptor signaling
in FGF2 inhibition of oligodendrocyte progenitor differentiation. Glia 54,
578–590. doi: 10.1002/glia.20410
Conflict of Interest Statement: The authors declare that the research was
conducted in the absence of any commercial or financial relationships that could
be construed as a potential conflict of interest.
Copyright © 2016 Rivera, Kazanis, Ghevaert and Aigner. This is an open-access
article distributed under the terms of the Creative Commons Attribution License (CC
BY). The use, distribution or reproduction in other forums is permitted, provided the
original author(s) or licensor are credited and that the original publication in this
journal is cited, in accordance with accepted academic practice. No use, distribution
or reproduction is permitted which does not comply with these terms.
Frontiers in Cellular Neuroscience | www.frontiersin.org 6 January 2016 | Volume 9 | Article 511
